Assessment of open label co-stimulation blockade with abatacept in children and adolescents with active juvenile idiopathic arthritis (JIA).

被引：0
|
作者：
Lovell, Daniel J.
Ruperto, Nicolino
Prieur, Anne-Marie
Paz, Eliana
Pérez, Nadina Eugenia Rubio
Silva, Clovis A.
Mendoza, Carlos Abud
Burgos-Vargas, Ruben
Magalhaes, Claudia
Melo-Gomes, Jose A.
Gerloni, Valeria
Sztajnbok, Flavio R.
Scheinberg, Morton
Sigal, Leonard
Block, Alan
Zhou, Ye
Cornet, Patricia L.
Pagliaro, Lori
Giannini, Edward
Martini, Alberto
机构：
[1] Cincinnati Childrens Hosp Med Ctr, PRCSG, Cincinnati, OH USA
[2] Ist Giannina Gaslini, IRCCS, PRINTO, I-16148 Genoa, Italy
[3] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S326 / S326
页数：1
相关论文
共 50 条
  • [21] Abatacept is well tolerated in a double-blind, randomised withdrawal study, with an open-label extension, in patients with juvenile idiopathic arthritis
    Quartier, P.
    Ruperto, N.
    Lovell, D. J.
    Paz, E.
    Rubio-Perez, N.
    Covucci, A.
    Segal, L.
    Giannini, E. H.
    Martini, A.
    RHEUMATOLOGY, 2008, 47 : II3 - II3
  • [22] The validity and reliability of the Juvenile Arthritis Functional Assessment Report (JAFAR) in children/adolescents with Juvenile Idiopathic Arthritis: The Turkish version study
    Bali, Merve
    Kabul, Elif Gur
    Calik, Bilge Basakci
    Yener, Gulcin Otar
    Tekin, Zahide Ekici
    Yuksel, Selcuk
    INTERNATIONAL JOURNAL OF ASSESSMENT TOOLS IN EDUCATION, 2023, 10 (03): : 532 - 543
  • [23] Re-establishment of clinical benefit in patients with juvenile idiopathic arthritis in whom abatacept, a CO-STIMULATION modulator, had been withdrawn for up to 6 months and then re-introduced
    Ruperto, N.
    Giannini, E. H.
    Quartier, P.
    Paz, E.
    Rubio Perez, N. E.
    Silva, C. A.
    Abud, C.
    Burgos-Vargas, R.
    Gerloni, V.
    Melo-Gomes, J. A.
    Saad-Magalhaes, C.
    Penades, I. Calvo
    Fischbach, M.
    Orozco, J.
    Jung, L.
    Lepore, L.
    Oliveira, S.
    Wallace, C.
    Sigal, L. H.
    Block, A. J.
    Sinisi, S.
    Comet, P. L. N.
    Pagliaro, L.
    Martini, A.
    Lovell, D. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 436 - 436
  • [24] Subcutaneous Abatacept in Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Results From a Phase III Open-Label Study
    Brunner, Hermine, I
    Tzaribachev, Nikolay
    Vega-Cornejo, Gabriel
    Louw, Ingrid
    Berman, Alberto
    Calvo Penades, Inmaculada
    Anton, Jordi
    Avila-Zapata, Francisco
    Cuttica, Ruben
    Horneff, Gerd
    Foeldvari, Ivan
    Keltsev, Vladimir
    Kingsbury, Daniel J.
    Oscar Viola, Diego
    Joos, Rik
    Lauwerys, Bernard
    Paz Gastanaga, Maria Eliana
    Elena Rama, Maria
    Wouters, Carine
    Bohnsack, John
    Breedt, Johannes
    Fischbach, Michel
    Lutz, Thomas
    Minden, Kirsten
    Mirava, Tatiana
    Ally, Mahmood M. T. M.
    Rubio-Perez, Nadina
    Gervais, Elisabeth Solau
    Van Zyl, Riana
    Li, Xiaohui
    Nys, Marleen
    Wong, Robert
    Banerjee, Subhashis
    Lovell, Daniel J.
    Martini, Alberto
    Ruperto, Nicolino
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (07) : 1144 - 1154
  • [25] Aerobic capacity and disease activity in children, adolescents and young adults with juvenile idiopathic arthritis (JIA) (vol 10, 27, 2012)
    Martini, Alberto
    Spencer, Charles
    PEDIATRIC RHEUMATOLOGY, 2013, 11
  • [26] CXCL13 Serum Levels and Circulating Follicular Helper T-Cells Decrease After Co-stimulation Blockade with Abatacept in Rheumatoid Arthritis
    Piantoni, Silvia
    Regola, Francesca
    Andreoli, Laura
    Tincani, Angela
    Airo, Paolo
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [27] Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
    Hara, Ryoki
    Umebayashi, Hiroaki
    Takei, Syuji
    Okamoto, Nami
    Iwata, Naomi
    Yamasaki, Yuichi
    Nakagishi, Yasuo
    Kizawa, Toshitaka
    Kobayashi, Ichiro
    Imagawa, Tomoyuki
    Kinjo, Noriko
    Amano, Norihito
    Takahashi, Yoko
    Mori, Masaaki
    Itoh, Yasuhiko
    Yokota, Shumpei
    PEDIATRIC RHEUMATOLOGY, 2019, 17 (1)
  • [28] Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study
    Ryoki Hara
    Hiroaki Umebayashi
    Syuji Takei
    Nami Okamoto
    Naomi Iwata
    Yuichi Yamasaki
    Yasuo Nakagishi
    Toshitaka Kizawa
    Ichiro Kobayashi
    Tomoyuki Imagawa
    Noriko Kinjo
    Norihito Amano
    Yoko Takahashi
    Masaaki Mori
    Yasuhiko Itoh
    Shumpei Yokota
    Pediatric Rheumatology, 17
  • [29] Efficacy and Safety of Ixekizumab in Children with Active Juvenile Psoriatic Arthritis and Enthesitis Related Arthritis (COSPIRIT-JIA): 16-week Results of a Multicentre, Randomised, Open-label Study
    Ramanan, Athimalaipet
    Ruperto, Nicolino
    Foeldvari, Ivan
    Vega Cornejo, Gabriel
    Keller, Stuart
    Wang, Rona
    Araujo, Joana
    Hojnik, Maja
    Sen, Priyanka
    Marulkar, Ketan
    Quartier, Pierre
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5222 - 5224
  • [30] Adjunctive vitamin D for the treatment of active juvenile idiopathic arthritis: An open-label, prospective, randomized controlled trial
    Tang, Tao
    Zhang, Yu
    Luo, Chong
    Liu, Mingyue
    Xu, Li
    Tang, Xuemei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (06) : 4921 - 4926
12345